1. During the COVID-19 pandemic, there were no backlogs in the distribution of medication. Additionally, there have been no major supply chain challenges related to the essential medicines during the pandemic period.
2. During the pandemic period, patients on chronic therapy, including patients on antiretorvirals, received at least two months’ supply of the medication in an effort to reduce pressure on facilities. Additionally, patients received medicines via the CCMDD programme.
END.